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Summary
QUESTION UNDER STUDY: Rehabilitation for cancer
patients aims to reduce physical disability and mental dis-
tress resulting from the disease and its treatment. However,
little is known about the use of cancer inpatient rehabilit-
ation in Switzerland in relation to sociodemographic and
medical characteristics. The main purpose of this study was
to evaluate whether there are differences in sociodemo-
graphic and medical characteristics between patients who
underwent inpatient rehabilitation (users) and those who
did not (nonusers).
METHODS: A total of 238 cancer patients from the
University Hospital Zurich were included. The sociodemo-
graphic and medical characteristics of inpatient rehabil-
itation users were assessed and compared with those of
nonusers. We analysed the differences between inpatient
rehabilitation users and nonusers.
RESULTS: Of the patients included, 101 (42.4%) used in-
patient rehabilitation. They were less likely to be employed
(p = 0.029), stayed longer in hospital (p <0.001), and were
more likely to have semiprivate or private supplementary
health insurance (p = 0.030) than nonusers. There were dif-
ferences in cancer site (p = 0.001). Patients with tumours
of the digestive organs or of the thoracic organs were more
likely to use rehabilitation, whereas breast cancer patients
were less likely to use it. Stratified analyses showed that
male patients with semiprivate or private supplementary
health insurance (p = 0.037), lower education (p = 0.039),
and lower likelihood of employment (p = 0.051) were more
likely to use rehabilitation. Women with an advanced tu-
mour stage used inpatient rehabilitation more often (p =
0.012).
CONCLUSIONS: Findings show the influence of duration
of hospitalisation, insurance type, cancer site, employment
status, and gender on the use of inpatient cancer rehabil-
itation. The results indicate the need of structured stand-
ardised procedures for medical referral to be implemented
based on screening.
Key words: rehabilitation; inpatient; cancer; health
services research; longitudinal study
Introduction
Cancer is one of the major issues in healthcare. It is the
second most frequent cause of death overall and the most
frequent cause of death in persons between 45 and 64 years
of age in Switzerland [1]. Over 38 000 new cancer cases
are diagnosed and about 16 500 patients die in Switzerland
each year [2]. The 5-year survival rate after an initial dia-
gnosis is 57% in women and 49% in men [3]. Around 4%
of the population in Switzerland live with a past cancer
diagnosis [4]. As a result of early diagnosis, prevention,
and progress in medical therapies, the number of long-
term cancer survivors has increased steadily over time.
Nowadays, cancer may be considered a chronic disease
rather than a lethal disease [1, 5].
Cancer patients frequently experience physical impairment
and psychological distress, which is associated with poor
quality of life (QoL) [6–15]. After exhaustive, acute med-
ical treatment, patients return to their former environments
without the energy and abilities that they had before. They
often experience difficulties in resuming their previous so-
cial and work roles. Physical and emotional burdens can
impair social functioning, which includes maintenance of
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friendships and relationships with family members [16].
Rehabilitation aims to reduce disabilities resulting from the
disease and its treatment by improving physical, social,
psychological and vocational functioning in order to return
to a premorbid condition [17, 18]. Rehabilitation also helps
patients to deal with possible residual disabilities so as
to maintain and regain independence, social integration
and participation in everyday life [19]. Available studies
suggest that cancer rehabilitation improves QoL, physical
health and psychological well-being [20–24].
Cancer rehabilitation programmes vary across countries
depending on the public health system and social security
legislation [25]. In the Anglo-Saxon countries and Nordic
European countries, outpatient rehabilitation is more com-
mon. In Switzerland, inpatient rehabilitation is the primary
pattern, as is the case in Germany [25–27]. Many studies
have focused on the benefits of specific rehabilitation in-
tervention strategies, such as exercise and aerobic pro-
grammes designed in outpatient settings [28–31]. Other
studies have reported the benefits of inpatient rehabilitation
in general [32–36]. However, many of these studies used a
pre-post design without control groups in evaluation stud-
ies [37], which limits their findings about the effectiveness
of rehabilitation.
Rehabilitation for cancer patients is often underused com-
pared with that for patients with other diseases, such as car-
diovascular diseases [38–40]. Cheville speculated that the
public perception of cancer as an unavoidable progressive
and terminal disease might have slowed the development
of cancer rehabilitation services in the past [39]. Some
studies have shown that many cancer patients were not
referred to rehabilitation after hospital discharge [12, 41,
42]. Patients were usually referred to rehabilitation at later
stages of the disease, when QoL and physical health was
already low. Hewitt suggested that more effective assess-
ment and structured procedures are required [10]. In Ger-
many, the use of cancer rehabilitation in inpatient and out-
patient settings has increased in recent years, because it is
considered an inherent part of treatment [43].
In Switzerland, cancer rehabilitation usually consists of
physiotherapeutic treatment and other specific treatments
(e. g. nutrition counselling, lymphatic drainage, psycho-
therapy). Inpatient rehabilitation usually lasts 2 to 3 weeks
and can be prolonged on request. Cancer rehabilitation can
also be performed in an outpatient setting. Bachmann et
al. found that case management in outpatient rehabilitation
can improve QoL of cancer patients after acute therapy in
Switzerland [44].
All Swiss residents must purchase basic health insurance,
which covers a standardised basic benefit package includ-
ing several health services. The basic health insurance can
be supplemented by semiprivate or private insurance
policies that give access to more extensive coverage than
basic health insurance, including options such as better
levels of accommodation or choice of physicians in hospit-
als [45].
Referral to rehabilitation requires several decisions, which
results in a rather complicated procedure. First, patients
might have to express their wish to attend rehabilitation,
and physicians have to estimate the potential for rehabilita-
tion for a specific patient. However, this is rarely based on a
standardised procedure. Second, even after such a positive
decision the rehabilitation must be reimbursed by health
insurance companies. Third, hospital social services have
to find a rehabilitation clinic with sufficient capacity. The
overall procedure presents several challenges. Good link-
age of acute care and rehabilitation is required.
Limited data are available for German-speaking countries
on differences in sociodemographic or medical character-
istics between cancer patients using (users) and not using
(nonusers) rehabilitation. Studies from Germany report no
differences in age, occupational position or marital status
[46–49]. Other studies have reported lower use of rehab-
ilitation in breast cancer patients who are self-employed,
are cohabiting with partners [27, 50–53] and have a shorter
duration of chemotherapy [53]. Geyer et al. found that
breast cancer patients with lower education were more
likely to undergo inpatient cancer rehabilitation [47]. This
is in contrast with more general findings that patients with
a lower socioeconomic status were less likely to undergo
rehabilitation [54]. Studies from Germany have shown that
breast cancer patients and younger patients with intestinal
tumours are more likely to undergo rehabilitation than pa-
tients with other cancer diagnoses. In terms of gender, data
also suggest that women are more likely to undergo cancer
inpatient rehabilitation than men [43].
In Switzerland, 18 rehabilitation clinics offer inpatient can-
cer rehabilitation. Most clinics are located in the German-
speaking part of Switzerland. About 14 000 patients use
inpatient rehabilitation, including internal/cancer rehabilit-
ation, per year, with a mean duration of 24 days in the clin-
ic [55–57]. Only about 1% of cancer patients undergo inpa-
tient rehabilitation after hospitalisation [58]. About 90% of
them are referred after acute inpatient treatment [58].
To date, no empirical data are available about the so-
ciodemographic and medical characteristics of patients un-
dergoing inpatient cancer rehabilitation in Switzerland.
More data would help to inform policy makers and prac-
titioners about the use of rehabilitation among cancer pa-
tients. Therefore, the purposes of this study were (1) to de-
scribe differences in sociodemographic and medical char-
acteristics between patients who undergo inpatient cancer
rehabilitation and patients who do not; and (2) to analyse
data stratified for women and men, since clinical character-
istics differ between these populations.
Methods
Participants and material
Patients aged at least 18 years with acute inpatient treat-
ment for cancer or for benign or malignant brain tumours
were recruited at the University Hospital Zurich and the
Balgrist University Hospital (Switzerland) between April
2013 and November 2014. Both the University Hospital
Zurich and the Balgrist University Hospital exclusively
provide acute health care and no rehabilitation for cancer
patients. Some 18.3% of all cancer cases in the area of
Zurich are treated at these hospitals [59]. We only included
patients from these two hospitals to ensure a similar referral
organisation procedure throughout the entire sample. As
some tumour sites are associated with cognitive impair-
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ment, which might be more severe in older subjects, we
screened patients aged ≥50 years for cognitive impairment
(Mini Mental State Examination [MMSE], cut-off of at
least 25 points) to ensure their cognitive ability to complete
the questionnaires [60]. The cut-off indicates a high chance
for mild to severe cognitive impairment. Furthermore, suf-
ficient German knowledge was required. These patients
were referred to six rehabilitation clinics in several regions
of Switzerland. Rehabilitation programmes are adapted to
the abilities and needs of the patient, in compliance with
the International Classification of Functioning, Disability
and Health (ICF) [61]. The study was approved by the
Cantonal Ethics Committee of Zurich (KEK-ZH Nr.
2012-0563).
Sociodemographic and medical data were obtained from
the patients’ clinical records. Additional sociodemographic
information regarding employment status, highest educa-
tion attained, marital/cohabitating status, children in house-
hold, income and treatments after hospitalisation was ob-
tained during hospitalisation with a standardised question-
naire, which was developed especially for this study. Com-
pleting the questionnaire took about 5 minutes. Referral
allocation to rehabilitation was decided by the physician re-
sponsible for acute management in agreement with the pa-
tient. Patients’ health insurance companies decided wheth-
er inpatient rehabilitation was reimbursed or not.
Measures
Tumour stage was classified according to the Tumour-
Node-Metastasis (TNM) Classification of Malignant Tu-
mours [62]. Thus, brain tumours and haematological ma-
lignancies were not included in the analysis of tumour
stage. The cancer sites were categorised according to the
World Health Organization (WHO) / International Agency
for Research on Cancer (IARC) Classification of Tumours,
fourth edition [63].
Analysis
First, participants and nonparticipants were compared. Se-
cond, the participating patients were divided into users
and nonusers. We compared sociodemographic and medic-
al characteristics. Since cancer sites differed substantially
between male and female patients, gender was included in
further analyses. Descriptive and medical data for women
and men with regard to use of inpatient rehabilitation are
provided in table 3 in numbers and percentages.
All statistical analyses were performed using the Statistical
Package for the Social Sciences version 21.0. As a result
of non-normal distribution, a Mann-Whitney-U test and a
Pearson chi-square test or a Fisher’s exact test as univariate
analysis were conducted to compare nonparticipants and
participants in order to determine biases in age, sex, nation-
ality, employment status, insurance type, cancer stage (ex-
cluding brain tumours and haematological malignancies),
cancer type, cancer site, treatment and duration of hospit-
alisation. The sociodemographic and medical data of the
nonparticipants are noted in appendix 1. The same statist-
ical analysis procedures were conducted to compare differ-
ences between inpatient rehabilitation users and nonusers
and for gender. All tests were two-tailed, and the level of
statistical significance was set at 95% confidence level (p
<0.05). We included age, sex, marital/cohabitating status,
children in household, insurance type, employment status,
cancer stage (excluding brain tumours and haematological
malignancies), cancer type, cancer site, treatment and dur-
ation of hospitalisation in the evaluation.
Results
Participants vs nonparticipants
A total of 341 patients were assessed for eligibility using
a consecutive sampling approach between April 2013 and
November 2014 (fig. 1 shows the patient flow). Forty-
two patients were excluded from completing the question-
naires because of cognitive or physical impairment (n =
19, 45.2% of the excluded patients) or limited knowledge
of German (n = 23, 55.8% of the excluded patients). Of
the 299 eligible patients, 61 (20.4%) refused to participate.
Finally, 238 (79.6% of the total assessed) patients were in-
cluded in the study. No significant differences were found
between participants and nonparticipants in age, national-
ity, health insurance type, tumour stage, cancer type or can-
cer site. Participants did not differ in treatment and use
of inpatient rehabilitation from nonparticipants. However,
study participants stayed in hospital longer than nonparti-
cipants (p = 0.014) (appendix 1).
Patients with and without use of inpatient
rehabilitation
Of the 238 cancer patients, 101 (42.4%) patients used in-
patient rehabilitation and 137 (57.6%) did not. Descriptive
information on users and nonusers is presented in table 1.
For the total sample of all patients,the median age was 61
years, with 52.1% (n = 124) aged below 61 years. The
sample consisted of 51.7% (n = 123) male patients. Three
quarters of the patients were married or cohabiting with
a partner (73.5%, n = 175), 15.5% (n = 37) had minors
in their household, and 48.7% (n = 116) were employed.
Half of the patients (n = 117) had completed apprentice-
ships, 10.1% (n = 24) basic school level, 14.3% (n = 34)
high school, and 22.2% (n = 62) university. No signific-
ant differences in sociodemographic characteristics were
found between rehabilitation users and rehabilitation no-
nusers excepting employment status (p = 0.029): rehabilit-
Figure 1
Flowchart of study participants vs nonparticipants, rehabilitation
users vs rehabilitation nonusers.
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ation users were less likely to be employed than rehabilita-
tion nonusers.
As table 2 shows, rehabilitation users stayed longer in hos-
pital (M = 20.7; SD = 10.5) than rehabilitation non-users
(M = 13.9; SD = 10.4) (p <0.001). The majority of patients
had basic insurance (71.8%, n = 171). Patients differed
in insurance type, since the percentage of patients with
semiprivate or private supplementary health insurance was
higher for rehabilitation users (p = 0.030). All tumour
stages were represented: 17.0% (n = 33) in stage I, 24.7%
(n = 48) in II, 27.3% (n = 53) in III and 30.9% (n = 60)
IV. The majority of patients underwent surgery (85.7%, n =
204) and suffered from carcinoma (63.9%, n = 152). There
were no differences between rehabilitation users and rehab-
ilitation nonusers regarding tumour stage, cancer type or
type of treatment. The most frequent diagnoses were tu-
mours of the head and neck (23.9%, n = 57), of the digest-
ive organs (14.7%, n = 35) and haematological malignan-
cies (12.6%, n = 30). Rehabilitation users and rehabilitation
nonusers differed in their cancer site (p = 0.001). Patients
with tumours of the digestive organs (p = 0.003) or of the
thoracic organs (p = 0.013) used rehabilitation more often,
whereas breast cancer patients were less likely to use re-
habilitation (p = 0.013).
Use of inpatient rehabilitation and gender
Women who underwent rehabilitation were longer in acute
treatment (M = 20.4; SD = 12) than those who did not use
rehabilitation (M = 12.3; SD = 10.3; p <0.001) (table 3).
Similar results were found for men (rehabilitation users M
= 21.0; SD = 9.1; rehabilitation nonusers M = 15.5; SD =
10.2; p <0.001). Neither female nor male patients differed
by age in the use of rehabilitation. Men who underwent re-
habilitation differed in the distribution of level of education
(p = 0.039) from those who did not. Employed men were
less likely to undergo rehabilitation (p = 0.051). Male pa-
tients with semiprivate or private supplementary health in-
surance used rehabilitation more often than men with ba-
sic health insurance (p = 0.037). Women with an advanced
tumour stage used inpatient rehabilitation more often (p
= 0.012). Women with tumours of the female genital or-
gans or with breast cancer were less likely to use rehabil-
itation (p = 0.023). Differences in cancer site were found
in both sexes (women p = 0.023; men p = 0.046). Men
with tumours of the digestive or of the thoracic organs were
more likely to undergo inpatient rehabilitation, while men
with haematological malignancies were less likely to do so
(trend).
Discussion
To our best knowledge, this is the first study that has ana-
lysed differences in sociodemographic and medical char-
acteristics between users and nonusers of inpatient cancer
rehabilitation in Switzerland. We found that rehabilitation
users and nonusers differed in medical and in sociodemo-
graphic characteristics. Users stayed longer in hospital, and
inpatient rehabilitation was more likely to be used by pa-
Table 1: Sociodemographic characteristics.
Total Rehabilitation users (n = 101) Rehabilitation nonusers (n =
137)
p-valueSociodemographic characteristics
n % n % n %
Age in years (median, IQR, range) 61.0 (±17.0, 20–88) 62.0 (±14.0, 20–84) 59.0 (±20.0, 20–88) 0.227 *
Age
<61
≥61
124
114
52.1
47.9
49
52
48.5
51.5
75
62
54.7
45.3
0.361 ¶
Sex
Male
Female
123
115
51.7
48.3
58
43
57.4
42.6
65
72
47.4
52.6
0.149 ¶
Marital/cohabitating status
Marital/Cohabiting
Living alone
175
63
73.5
26.5
72
29
71.3
28.7
103
34
75.2
24.8
0.553 ¶
Children ≤18 years living at home
No children
Children
37
201
15.5
84.5
13
88
12.9
87.1
24
113
17.5
82.5
0.369 ¶
Nationality
Swiss
Other
210
28
88.2
11.8
92
9
91.1
8.9
118
19
86.1
13.9
0.310 ¶
Level of education †,§
Obligatory school
Apprenticeship
High school
University
24
117
34
62
10.1
49.4
14.3
26.2
10
50
18
23
9.9
49.5
17.8
22.8
14
67
16
39
10.3
49.3
11.8
28.7
0.770 ‡
Employment status
Employed
Unemployed, IV compensation
Retired
116
27
95
48.7
11.3
39.9
40
16
45
39.6
15.8
44.6
76
11
50
55.5
8.0
36.5
0.029 ‡
n = 238
IQR = interquartile range; IV = invalidity benefit
* Mann-Whitney U-test
¶ Fisher’s exact test
† missing n = 1
§ compulsory school (aged ≥6 years); apprenticeship (aged ≥15 years); high school (aged ≥15 years); university (aged ≥19 years)
‡ Pearson chi-square test
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tients with tumours of the digestive organs or of the
thoracic organs and less likely by breast cancer patients. In-
terestingly, inpatient rehabilitation users were more likely
to have semiprivate or private supplementary health insur-
ance and were less likely to be employed than nonusers.
This is an important finding that needs further empirical in-
vestigation, since it indicates that social factors might fa-
cilitate rehabilitation use or be obstacles for rehabilitation
use.
Our study is in line with reports in Switzerland that patients
with semiprivate or private supplementary health insurance
are more likely to use inpatient rehabilitation [57, 64, 65].
This finding might be explained by the higher chance of
such patients obtaining the rehabilitation more promptly.
This finding does not coincide with better education of
users, since education did not predict rehabilitation use in
the current study. Indeed, the opposite was the case: Simil-
arly to Geyer et al., we found that rehabilitation users had a
lower education than nonusers, especially among men [47].
This finding might be explained by the higher motivation
of more educated patients to return to work [66–68]. Ac-
cording to Lehmann et al., our study reveals that employed
patients, especially men, were less likely to undergo cancer
inpatient rehabilitation [48]. Returning to work, and there-
fore to normal, as soon as possible might be a strategy for
coping with cancer among employed cancer patients [69,
70]. Mehnert has shown that men with cancer in particu-
lar often return to work and show a shorter period of oc-
cupational disability [71]. Women might tend to make their
decision in relation to family or children [72], a possibility
which unfortunately was not assessed in our study. Anoth-
er possible explanation is that nonusers were less impaired
than users before rehabilitation and consequently more of-
ten in employment.
Our results suggest that women with more advanced cancer
more often use rehabilitation. One explanation might be
that women with less impairment prefer to stay at home
with their relatives to reassume their social role as soon as
possible [72]. However, they might recognise the need for
rehabilitation later. In our study, women with breast or fe-
male genital organs cancers did not often use inpatient re-
habilitation, which is in contrast to findings from Germany
[26, 47, 53]. In Germany, cancer patients might use rehab-
ilitation even after acute outpatient treatment (e. g. chemo-
therapy, radiotherapy) with less severe impairment [58]. In
our study, women with breast or female genital organ can-
Table 2: Medical characteristics.
Total Rehabilitation users (n = 101) Rehabilitation nonusers (n =
137)
p-valueMedical characteristics
n % n % n %
Duration of hospitalisation (median, IQR, range) 15.0 (±11.0, 2–81) 19.0 (±8.0, 7–81) 12.0 (±10.0, 2–78) <0.001*
Insurance type
Basic
Semiprivate, private supplementary
171
67
71.8
28.2
65
36
64.4
35.6
106
31
77.4
22.6
0.030 ¶
Tumour stage †
I
II
III
IV
33
48
53
60
17.0
24.7
27.3
30.9
10
22
23
30
11.8
25.9
27.1
35.3
23
26
30
30
21.1
23.9
27.5
27.5
0.326 §
Cancer site
Head and neck
Digestive organs
Female genital organs
Breast
Haematological malignancies
Thoracic organs
Sarcoma extremities
Brain
Other ‡
57
35
25
23
30
22
21
14
11
23.9
14.7
10.5
9.7
12.6
9.2
8.8
5.9
4.6
26
23
8
4
12
15
5
4
4
25.7
22.8
7.9
4.0
11.9
14.9
5.0
4.0
4.0
31
12
17
19
18
7
16
10
7
22.6
8.8
12.4
13.9
13.1
5.1
11.7
7.3
5.1
0.001 §
Cancer type
Carcinoma
Sarcoma
Brain tumour
Lymphoma
Multiple myeloma
Other **
152
32
14
16
14
10
63.9
13.4
5.9
6.7
5.9
4.2
67
13
4
6
6
5
66.3
12.9
4.0
5.9
5.9
5.0
85
19
10
10
8
5
62.0
13.9
7.3
7.3
5.8
3.6
0.888 §
Type of treatment
Surgery
Stem cell transplantation
Other ¶¶
204
20
14
85.7
8.4
5.9
88
7
6
87.1
6.9
5.9
116
13
8
84.7
9.5
5.8
0.781 §
n = 238.
IQR = interquartile range
* Mann-Whitney U-test
¶ Fisher’s exact test
† n = 194, brain tumour and haematological malignancies excluded (missing n = 44)
§ Pearson chi-square test
‡ melanoma, endocrine tumour, urinary tract
** mesothelioma, melanoma, endocrine tumour
¶¶ radiotherapy, chemotherapy, photo-dynamic therapy, other inpatient care
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Table 3: Characteristics for women and men with regard to use of inpatient rehabilitation.
Total Rehabilitation users Rehabilitation nonusers p-valueCharacteristics
n % n % n %
Women
Duration of hospitalisation (median, IQR, range) 13.0 (±11.0, 2–81) 19.0 (±9.0, 7–81) 11.0 (±9.0, 2–78) <0.001 *
Age
<61
≥61
65
50
56.5
43.5
23
20
53.5
46.5
42
30
58.3
41.7
0.698 ¶
Marital/cohabitating status
Married/cohabiting
Living alone
73
42
63.5
36.5
24
19
55.8
44.2
49
23
68.1
31.9
0.231 ¶
Level of education †
Obligatory school
Apprenticeship
High school
University
16
57
16
25
14.0
50.0
14.0
21.9
9
19
6
9
20.9
44.2
14.0
20.9
7
38
10
16
9.9
53.5
14.1
22.5
0.417 §
Employment status
Employed
Unemployed, IV compensation
Retired
53
19
43
46.1
16.5
37.4
17
11
15
39.5
25.6
34.9
36
8
28
50.0
11.1
38.9
0.124 §
Insurance type
Basic
Semiprivate, private supplementary
79
36
68.7
31.3
27
16
62.8
37.2
52
20
72.2
27.8
0.306 ¶
Tumour stage ‡
I
II
III
IV
18
20
28
29
18.9
21.1
29.5
30.5
1
9
10
15
2.9
25.7
28.6
42.9
17
11
18
14
28.3
18.3
30.0
23.3
0.012 §
Cancer site
Head and neck
Digestive organs
Female genital organs
Breast
Haematological malignancies
Thoracic organs
Sarcoma extremities
Brain
Other **
16
13
25
23
9
6
10
11
2
13.9
11.3
21.7
20.0
7.8
5.2
8.7
9.6
1.7
6
8
8
4
4
5
2
4
2
14.0
18.6
18.6
9.3
9.3
11.6
4.7
9.3
4.7
10
5
17
19
5
1
8
7
0
13.9
6.9
23.6
26.4
6.9
1.4
11.1
9.7
0
0.023 §
Men
Duration (median/IQR) of hospitalisation 17.0 (±11.0, 2 – 65) 18.5 (±7.0, 10 – 65) 14.0 (±12.0, 2 – 53) <0.001 *
Age
<61
≥61
59
64
48.0
52.0
26
32
44.8
55.2
33
32
50.8
49.2
0.589 ¶
Marital/cohabitating status
Married/cohabiting
Living alone
102
21
82.9
17.1
48
10
82.8
17.2
54
11
83.1
16.9
1.000 ¶
Level of education
Obligatory school
Apprenticeship
High school
University
8
60
18
37
6.5
48.8
14.6
30.1
1
31
12
14
1.7
53.4
20.7
24.1
7
29
6
23
10.8
44.6
9.2
35.4
0.039 §
Employment status
Employed
Unemployed, IV compensation
Retired
63
8
52
51.2
6.5
42.3
23
5
30
39.7
8.6
51.7
40
3
22
61.5
4.6
33.8
0.051 §
Insurance type
Basic
Semiprivate, private supplementary
92
31
74.8
25.2
38
20
65.5
34.5
54
11
83.1
16.9
0.037 ¶
Tumour stage ¶
I
II
III
IV
15
28
25
31
15.2
28.3
25.3
31.3
9
13
13
15
18.0
26.0
26.0
30.0
6
15
12
16
12.2
30.6
24.5
32.7
0.848 §
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Cancer site
Head and neck
Digestive organs
Haematological malignancies
Thoracic organs
Sarcoma extremities
Brain
Other ††
41
22
21
16
11
3
9
33.3
17.9
17.1
13.0
8.9
2.4
7.3
20
15
8
10
3
0
2
34.5
25.9
13.8
17.2
5.2
0
3.4
21
7
13
6
8
3
7
32.3
10.8
20.0
9.2
12.3
4.6
10.8
0.046 §
Women n = 115; men n = 123
IQR =interquartile range; IV = invalidity benefit
* Mann-Whitney U-test.
¶ Fisher’s exact test
† missing n = 1
§ Pearson chi-square test
‡ n = 95, brain tumour and haematological malignancies excluded (missing n = 20)
** Melanoma, endocrine tumour.
¶¶ n = 99, brain tumour and haematological malignancies excluded (missing n = 24)
†† Melanoma, endocrine tumour, urinary tract
cers might not meet criteria for referral as these conditions
might lead to less impairment than other cancers. This ex-
planation appears quite plausible, since women with breast
cancer stayed less time in hospital than patients with other
cancer diagnoses.
Our study has some limitations that should be considered in
the interpretation of our findings. The broad inclusion cri-
teria increase the external validity of our results, but such
an approach limits the interpretation for specific diagnoses
and patient groups. We were only able to run stratified ana-
lyses for gender, but other variables such as education or
age could provide meaningful results in a larger sample. In
addition, the value of our dataset could have been increased
by inclusion of measures of psychopathology and quality
of life, as well as stress tests such as the 6-minute walk test
or the sit-to-stand test. Unfortunately, limited funding did
not allow for a more comprehensive data collection in this
study.
A strength of our study is the design, which facilitated the
collection of data on nonusers of rehabilitation. The bal-
anced number of users and nonusers made the comparis-
on of both groups feasible. Another strength of our study
was the data assessment within different healthcare set-
tings. Acute care and rehabilitation should be well connec-
ted, but such studies are rarely done, since the transfer of
patients to another system increases problems in data col-
lection. Studies often focus either on acute care or rehabil-
itation, so this study fills an important gap.
This study provides a basis for further research on this is-
sue. Studies focused on specific diagnoses or with a larger
sample are required.
Conclusion
This is the first study that examined the use of inpatient
rehabilitation among cancer patients in Switzerland. Our
study revealed that referral to inpatient rehabilitation is
highly associated with more severe illness, but also with
sociodemographic factors such as health insurance and em-
ployment, particularly in men. However, the latter indicates
that decisions for referrals to inpatient rehabilitation may
not be regularly based on medical factors, so cancer pa-
tients with regular work and no semiprivate or private sup-
plementary health insurance might underuse rehabilitation.
Additionally, our findings provide evidence that gender
might influence the use of inpatient cancer rehabilitation.
Consequently, more specific and standardised tools assess-
ing medical and psychosocial factors are needed to better
and more reliably identify patients who need inpatient can-
cer rehabilitation.
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Appendix 1
Table: Sociodemographic and medical characteristics
Total Participants (n = 238) Nonparticipants (n =61) p-valueCharacteristics
n % n % n %
Age in years (median, IQR, range) 61.0 (±17.0, 19–88) 61.0 (±17.0, 20–88) 63.0 (±22.0, 19–86) 0.266 *
Duration of hospitalisation (median, IQR, range) 15.0 (±11.0, 2–81) 15.0 (±11.0, 2–81) 12.0 (±10.0, 3–45) 0.014 *
Rehabilitation
Users
Nonusers
121
178
40.5
59.5
101
137
42.4
57.6
20
41
32.8
67.2
0.190 ¶
Sex
Male
Female
146
153
48.8
51.2
123
115
51.7
48.3
23
38
37.7
62.3
0.062 ¶
Age
<61 years
≥61 years
150
149
50.2
49.8
124
114
52.1
47.9
26
35
42.6
57.4
0.199 ¶
Nationality
Swiss
Other
264
35
88.3
11.7
210
28
88.2
11.8
54
7
88.5
11.5
1.000 ¶
Employment status †
Employed
Unemployed, IV compensation
Retired
137
38
122
46.1
12.8
41.1
116
27
95
48.7
11.3
39.9
21
11
27
35.6
18.6
45.8
0.127 §
Insurance type
Basic
Semiprivate, private
218
81
72.9
27.1
171
67
71.8
28.2
47
14
77.0
23.0
0.519 ¶
Tumour stage ‡
I
II
III
IV
47
54
67
73
19.5
22.4
27.8
30.3
33
48
53
61
16.9
24.6
27.2
31.3
14
6
14
12
30.4
14.6
30.4
29.3
0.103 §
Cancer Site
Head and Neck
Digestive organs
Female genital organs
Breast
Haematological malignancies
Thoracic organs
Sarcoma extremities
Brain
Other **
69
43
35
29
36
30
23
23
11
23.1
14.4
11.7
9.7
12.0
10.0
7.7
7.7
3.7
57
35
25
23
30
22
21
14
11
23.9
14.7
10.5
9.7
12.6
9.2
8.8
5.9
4.6
12
8
10
6
6
8
2
9
0
19.7
13.1
16.4
9.8
9.8
13.1
3.3
14.8
0
0.124 §
Cancer type
Carcinoma
Sarcoma
Brain tumour
Lymphoma
Multiple myeloma
Other ¶¶
197
34
22
17
18
11
65.9
11.4
7.4
5.7
6.0
3.7
152
32
14
16
14
10
63.9
13.4
5.9
6.7
5.9
4.2
45
2
8
1
4
1
73.8
3.3
13.1
1.6
6.6
1.6
0.039 §
Type of treatment
Surgery
Stem cell transplantation
Other ††
258
27
14
86.3
9.0
4.7
204
20
14
85.7
8.4
5.9
54
7
0
88.5
11.5
0
0.126 §
n = 299.
IQR = interquartile range; IV = invalidity benefit
* Mann-Whitney-U test
¶ Fisher’s exact test
† missing n = 2
§ Pearson chi-square test.
‡ n = 240, brain tumour and haematological malignancies excluded (missing n =59)
** melanoma, endocrine tumour, urinary tract
¶¶ mesothelioma, melanoma, endocrine tumour
†† radiotherapy, chemotherapy, photodynamic therapy, other inpatient care
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Figures (large format)
Figure 1
Flowchart of study participants vs nonparticipants, rehabilitation users vs rehabilitation nonusers.
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